Results 91 to 100 of about 3,690 (153)

Cefiderocol Resistance in <i>Pseudomonas aeruginosa</i> ST175: A Case Report with Genomic Analysis. [PDF]

Antibiotics (Basel)
Fernández RF, Carrasco AB, Porcuna NC, Cabezas AM, Ruiz MC.   +4 more
europepmc   +1 more source

Cefiderocol Sulfate Tosylate

American Journal of Health-System Pharmacy, 2020
openaire   +1 more source

Risk factors and treatment advances for carbapenem-resistant Enterobacteriaceae infections in the urinary tract. [PDF]

Front Cell Infect Microbiol
Zhang X, Miao S, Ji C, Hu W.
europepmc   +1 more source

Genomic diversity and adaptive resistance mechanisms in <i>Pseudomonas aeruginosa</i> from bronchiectasis. [PDF]

mSystems
Xiao Y, Zhang J, Nie F, Peng T, Li P, Li K, Tao X, Wei D, Zheng F, Zhao R, Zhang W.   +10 more
europepmc   +1 more source

Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion. [PDF]

Pharmaceutics
Trozzi I, Giorgi B, De Paola R, Gatti M, Pea F.   +4 more
europepmc   +1 more source

Management of metallo-β-lactamase-producing Enterobacterales infections: a modified Delphi study. [PDF]

JAC Antimicrob Resist
Carmeli Y, Price M, Daikos GL, Falcone M, Gales AC, Hagel S, Omrani AS, Ramirez P, Todi S, Wang M, Gheorghe M, Hauber B, Little CJ, Townsend A.   +13 more
europepmc   +1 more source

Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa. [PDF]

Antimicrob Agents Chemother
González-Pinto L, Gomis-Font MA, Pérez-Rodríguez G, Blanco-Martín T, Rodríguez-Pallares S, Sánchez-Peña L, Beceiro A, Bou G, Jeannot K, Oliver A, Arca-Suárez J.   +10 more
europepmc   +1 more source

In Vitro Activity of Cefiderocol Against Multi-Drug-Resistant Gram-Negative Clinical Isolates in Romania. [PDF]

Antibiotics (Basel)
Baicus A, Sisu VD, Tatar AD, Gherghel A, Iacob DG, Pop CS, Cirstoiu CF.   +6 more
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source